LONAY, Switzerland--(BUSINESS WIRE)--Swiss company Leman Cardiovascular (“LCV”) today announced that, through its US subsidiary Hancock Jaffe Laboratories, it has signed a partnership deal with Cook® Medical, based in Bloomington, Indiana. The partnership deal covers product development in the field of tissue engineering and processing for minimally invasive cardiovascular indications and contract manufacturing. The market potential of the product under development amounts to USD 600 million annually in the US alone.
